Verition Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-204,808
| Closed | -$8.37M | – | 2858 |
|
|
2024
Q2 | $8.37M | Buy |
204,808
+71,985
| +54% | +$2.94M | 0.05% | 370 |
|
|
2024
Q1 | $5.61M | Buy |
132,823
+52,823
| +66% | +$2.23M | 0.04% | 471 |
|
|
2023
Q4 | $3.39M | Buy |
+80,000
| New | +$3.39M | 0.03% | 523 |
|
|
2022
Q4 | – | Sell |
-19,457
| Closed | -$550K | – | 2315 |
|
|
2022
Q3 | $550K | Buy |
+19,457
| New | +$550K | 0.01% | 1447 |
|
|
2022
Q2 | – | Sell |
-82,135
| Closed | -$2.88M | – | 2466 |
|
|
2022
Q1 | $2.88M | Buy |
+82,135
| New | +$2.88M | 0.03% | 500 |
|
|
2021
Q3 | – | Sell |
-37,528
| Closed | -$961K | – | 2118 |
|
|
2021
Q2 | $961K | Sell |
37,528
-223,976
| -86% | -$5.74M | 0.01% | 714 |
|
|
2021
Q1 | $3.59M | Buy |
261,504
+226,074
| +638% | +$3.1M | 0.04% | 203 |
|
|
2020
Q4 | $587K | Buy |
35,430
+5,929
| +20% | +$98.2K | 0.01% | 524 |
|
|
2020
Q3 | $308K | Buy |
+29,501
| New | +$308K | 0.01% | 689 |
|